Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study
- Posted on June 10, 2026
- By South China Morning Post
- 0 Views
- 1 min read
Targeted therapy could turn advanced lung cancer into chronic illness: CUHK study
Clinical trial finds 55 per cent of patients on lorlatinib experience no disease progression for at least seven years.
